These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 20068224)
21. Autoimmune lymphoproliferative syndrome: an update and review of the literature. Shah S; Wu E; Rao VK; Tarrant TK Curr Allergy Asthma Rep; 2014 Sep; 14(9):462. PubMed ID: 25086580 [TBL] [Abstract][Full Text] [Related]
22. Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort. Lau CY; Mihalek AD; Wang J; Dodd LE; Perkins K; Price S; Webster S; Pittaluga S; Folio LR; Rao VK; Olivier KN Ann Am Thorac Soc; 2016 Aug; 13(8):1279-88. PubMed ID: 27268092 [TBL] [Abstract][Full Text] [Related]
23. Looking for ALPS: The value of a combined assessment of biochemical markers. Fernandez I; Touzot F Pediatr Allergy Immunol; 2024 May; 35(5):e14135. PubMed ID: 38700373 [TBL] [Abstract][Full Text] [Related]
24. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports. Cayrol J; Garrido Colino C J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735 [TBL] [Abstract][Full Text] [Related]
26. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Neven B; Magerus-Chatinet A; Florkin B; Gobert D; Lambotte O; De Somer L; Lanzarotti N; Stolzenberg MC; Bader-Meunier B; Aladjidi N; Chantrain C; Bertrand Y; Jeziorski E; Leverger G; Michel G; Suarez F; Oksenhendler E; Hermine O; Blanche S; Picard C; Fischer A; Rieux-Laucat F Blood; 2011 Nov; 118(18):4798-807. PubMed ID: 21885602 [TBL] [Abstract][Full Text] [Related]
27. Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease. Miano M; Madeo A; Cappelli E; Lanza F; Lanza T; Stroppiano M; Terranova P; Venè R; Bleesing JJH; Di Rocco M J Allergy Clin Immunol Pract; 2020; 8(10):3535-3542. PubMed ID: 32702516 [TBL] [Abstract][Full Text] [Related]
28. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Oliveira JB; Bleesing JJ; Dianzani U; Fleisher TA; Jaffe ES; Lenardo MJ; Rieux-Laucat F; Siegel RM; Su HC; Teachey DT; Rao VK Blood; 2010 Oct; 116(14):e35-40. PubMed ID: 20538792 [TBL] [Abstract][Full Text] [Related]
29. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia. Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548 [TBL] [Abstract][Full Text] [Related]
30. [Advances in the knowledge and management of autoimmune lymphoproliferative syndrome]. Garrido Colino C An Pediatr (Barc); 2014 Feb; 80(2):122.e1-7. PubMed ID: 24055319 [TBL] [Abstract][Full Text] [Related]
31. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS). Casamayor-Polo L; López-Nevado M; Paz-Artal E; Anel A; Rieux-Laucat F; Allende LM Crit Rev Clin Lab Sci; 2021 Jun; 58(4):253-274. PubMed ID: 33356695 [TBL] [Abstract][Full Text] [Related]
32. A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome. Dekeyser C; Naesens L; Offner F; De Vriendt C; Schauwvlieghe A; Kerre T; Laureys G J Neuroimmunol; 2022 Jun; 367():577866. PubMed ID: 35453041 [TBL] [Abstract][Full Text] [Related]
33. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies. Consonni F; Gambineri E; Favre C Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842 [TBL] [Abstract][Full Text] [Related]
34. Tubulointerstitial nephritis in a patient with probable autoimmune lymphoproliferative syndrome. Glerup M; Herlin T; Rittig S; Grønbæk K; Hokland M; Hasle H J Pediatr Hematol Oncol; 2013 Jul; 35(5):e187-9. PubMed ID: 23588339 [TBL] [Abstract][Full Text] [Related]